HUMANE ANTIKÖRPER WELCHE AN HUMANEN TNFalpha BINDEN

Patent europeic · EP0929578 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP0929578
Numer da la dumonda
EP97906572
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
10-02-1997
Publitgà
21-07-1999
Concedì
02-05-2003
Stritgà
09-02-2017
Motiv
Durada maximala cuntanschida
Classas IPC
C07K 16/24 (2006.01)
C12N 15/13 (2006.01)
C12N 15/64 (2006.01)
C12N 5/10 (2006.01)
C12N 1/21 (2006.01)
A61K 39/395 (2006.01)
G01N 33/68 (2006.01)
Prioritad
US 599226 09.02.1996
US 31476 P 25.11.1996
Dumonda PCT
PCT/US1997/002219 10.02.1997
Publicaziun PCT
WO1997/029131 14.08.1997
Lingua da l’annunzia
englais
Funtauna
Swissreg

Certificats cumplementars da protecziun

In certificat prolunghescha la protecziun dal patent per in medicament u in product da protecziun da plantas admess en Svizra.

Adalimumab

C00929578/01 · Medicament · Concedì · Protecziun dals 10-02-2017 fin ils 15-04-2018

Admissiun 56221 (Swissmedic, 16-04-2003)

Stritgà, Durada maximala cuntanschida

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 24-10-2024

    Curregì

    Published in Swissreg on 24.10.2024

  2. 13-02-2017

    Durada maximala cuntanschida

    Published in Swissreg on 13.02.2017

  3. 12-07-2014

    Adressa midada

    Representative
    BOHEST AG, Postfach 160, 4003 Basel → BOHEST AG, Holbeinstrasse 36-38, 4051 Basel

    Published in Swissreg on 12.07.2014

  4. 28-03-2014

    Adressa midada

    Owner
    Abbott Biotechnology Ltd., Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda → AbbVie Biotechnology Ltd., Clarendon House, 2, Church Street, Hamilton HM 11, Bermuda

    Published in Swissreg on 28.03.2014

  5. 30-06-2008

    Adressa midada

    Representative
    A. Braun, Braun, Héritier,, Eschmann AG, Patentanwälte, Holbeinstrasse 36-38, 4051 Basel → BOHEST AG, Postfach 160, 4003 Basel

    Published in +pat+ No 12 in 2008

  6. 31-03-2004

    Transferì

    Owner
    Abbott Laboratories (Bermuda) Ltd., Clarendon House,, 2 Church Street, Hamilton HM 11, Bermuda → Abbott Biotechnology Ltd., Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda

    Published in +pat+ No 6 in 2004

  7. 29-08-2003

    Transferì

    Owner
    BASF Aktiengesellschaft, Carl-Bosch-Strasse 38, 67063 Ludwigshafen, Germany → Abbott Laboratories (Bermuda) Ltd., Clarendon House,, 2 Church Street, Hamilton HM 11, Bermuda

    Published in +pat+ No 16 in 2003

  8. 29-08-2003

    Represchentant inscrit

    Representative
    A. Braun, Braun, Héritier,, Eschmann AG, Patentanwälte, Holbeinstrasse 36-38, 4051 Basel

    Published in +pat+ No 16 in 2003

1 endataziun pli veglia
  1. 15-05-2003

    Concedì

    Published in +pat+ No 9 in 2003

Partidas

Possessur

AbbVie Biotechnology Ltd

AbbVie Biotechnology Ltd.

Clarendon House 2, Church Street, Hamilton HM 11, BM

Represchentant

BOHEST AG

Holbeinstrasse 36-38, 4051 Basel

Inventur

SALFELD, Jochen, G.

North Grafton, MA 01536, US

ALLEN, Deborah, J.

London N17 9YD, GB

KAYMAKCALAN, Zehra

Westboro, MA 01581, US

LABKOVSKY, Boris

Framingham, MA 01701, US

MANKOVICH, John, A.

Andover, MA 01810, US

MCGUINESS, Brian, T.

Cambridge CB2 5HP, GB

ROBERTS, Andrew, J.

Cambridge CB1 3AE, GB

SAKORAFAS, Paul

Shrewsbury, MA 01545, US

HOOGENBOOM, Hendricus, R., J., M.

B-3500 Hasselt, BE

SCHOENHAUT, David

Clifton, NJ 07011, US

VAUGHAN, Tristan, J.

Cambridge CB4 4NZ, GB

WHITE, Michael

Framingham, MA 01701, US

WILTON, Alison, J.

Cambridge CB3 0HH, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.